Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 15839378)

1.

Optimization and technological development strategies of an antimicrobial extract from Achyrocline alata assisted by statistical design.

Demarque DP, Fitts SM, Boaretto AG, da Silva JC, Vieira MC, Franco VN, Teixeira CB, Toffoli-Kadri MC, Carollo CA.

PLoS One. 2015 Feb 24;10(2):e0118574. doi: 10.1371/journal.pone.0118574. eCollection 2015.

2.

Hormesis results in trade-offs with immunity.

McClure CD, Zhong W, Hunt VL, Chapman FM, Hill FV, Priest NK.

Evolution. 2014 Aug;68(8):2225-33. doi: 10.1111/evo.12453. Epub 2014 Jun 20.

3.

The effect of aflatoxin-B1 on red drum (Sciaenops ocellatus) and assessment of dietary supplementation of NovaSil for the prevention of aflatoxicosis.

Zychowski KE, Hoffmann AR, Ly HJ, Pohlenz C, Buentello A, Romoser A, Gatlin DM, Phillips TD.

Toxins (Basel). 2013 Sep 16;5(9):1555-73. doi: 10.3390/toxins5091555.

4.

Risk-based indicators of Canadians' exposures to environmental carcinogens.

Setton E, Hystad P, Poplawski K, Cheasley R, Cervantes-Larios A, Keller CP, Demers PA.

Environ Health. 2013 Feb 12;12:15. doi: 10.1186/1476-069X-12-15.

5.

The role of x-rays in the treatment of gas gangrene: a historical assessment.

Calabrese EJ, Dhawan G.

Dose Response. 2012 Dec;10(4):626-43. doi: 10.2203/dose-response.12-016.Calabrese. Epub 2012 Apr 24.

6.

Hormesis provides a generalized quantitative estimate of biological plasticity.

Calabrese EJ, Mattson MP.

J Cell Commun Signal. 2011 Mar;5(1):25-38. doi: 10.1007/s12079-011-0119-1. Epub 2011 Feb 25.

7.

Cancer immunotherapy by immunosuppression.

Prehn RT, Prehn LM.

Theor Biol Med Model. 2010 Dec 15;7:45. doi: 10.1186/1742-4682-7-45.

8.

Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP.

Antioxid Redox Signal. 2010 Dec 1;13(11):1763-811. doi: 10.1089/ars.2009.3074. Epub 2010 Aug 28. Review.

9.

Biphasic dose response in low level light therapy.

Huang YY, Chen AC, Carroll JD, Hamblin MR.

Dose Response. 2009 Sep 1;7(4):358-83. doi: 10.2203/dose-response.09-027.Hamblin.

10.

Interpreting 'dose-response' curves using homeodynamic data: with an improved explanation for hormesis.

Stebbing AR.

Dose Response. 2009 Apr 15;7(3):221-33. doi: 10.2203/dose-response.08-020.Stebbing.

11.

Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.

Rother KI, Brown RJ, Morales MM, Wright E, Duan Z, Campbell C, Hardin DS, Popovic J, McEvoy RC, Harlan DM, Orlander PR, Brod SA.

Diabetes Care. 2009 Jul;32(7):1250-5. doi: 10.2337/dc08-2029. Erratum in: Diabetes Care. 2009 Sep;32(9):1751.

12.

Immunomodulatory effects of domoic acid differ between in vivo and in vitro exposure in mice.

Levin M, Leibrecht H, Ryan J, Van Dolah F, De Guise S.

Mar Drugs. 2008;6(4):636-59. doi: 10.3390/md6040636. Epub 2008 Dec 22.

13.

Hormesis [biological effects of low level exposures (BELLE)] and dermatology.

Thong HY, Maibach HI.

Dose Response. 2008 Feb 1;6(1):1-15. doi: 10.2203/dose-response.07-029.Thong.

14.

The importance of hormesis to public health.

Cook R, Calabrese EJ.

Environ Health Perspect. 2006 Nov;114(11):1631-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk